Pink Esthetic ScoreNCT07539168
Factors Affecting Immediate Anterior Implants Esthetics.
An observational study of Pink Esthetic Score and Implant Survival Rate, run by International Dental Contiuing Education.
Trial summary
This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla. Read more about this study
- Who is it for?
- Ages 21 to 55 years
- Conditions the study is for
- Pink Esthetic Score, Implant Survival Rate, Immediate Implant Placement
- How many people
- 500 participants
- Where
- No sites listed yet
- Study dates
- 1 Jun 2026to 1 Sep 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 55 years
- All sexes
- No healthy volunteers
- Adult
Study population: All patients were treated with flapless immediate implants with no grafting procedures in the esthetic zone.
Who may be able to join
- flapless immediately placed implants in esthetic zone with 3 years follow up CBCT,
- presence of immediate postoperative CBCT,
- initial intact thick gingival biotype with at least 2 mm band of keratinized tissue
- thin intact labial bone plate (< 1mm) extending 7 mm apically assessed by CBCT with good apical bone
- patients who had provided an informed consent.
Who cannot join
- patients with medical conditions that would compromise the surgical procedures, uncontrolled diabetes mellitus, taking IV bis-phosphonates for treatment of osteoporosis
- patients with active infection related at the site of implant and patients with untreated active periodontal diseases.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Factors Affecting Immediate Anterior Implants Esthetics . Clinical Retrospective Study
This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla. The primary objective is to identify predictors of implant survival and complications (e.g., infection, soft-tissue dehiscence, esthetic failure) within 12 months following placement. Secondary objectives include assessment of peri-implant marginal bone loss, prosthetic complications, and esthetic outcomes (pink esthetic score).
Read the detailed description
Study design:
Retrospective observational cohort study using existing patient records and radiographs from IDCE between September 2022 -March 2026. Data extraction will be performed blinded to outcome assessment.
Participants:
Subjects who received immediate implant placement in the anterior region (canine to canine) during the study period with at least 12 months follow-up. Expected sample size: approximately 500 patients/implants
- Keywords
- Immediate implant, esthetics, anterior maxilla
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| IIP in anterior maxilla | Immediate implant placement from canine to canine |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pink esthetic score
Measured: 3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Apr 2026
- Study start1 Jun 2026 (estimated)
- Primary completion1 Aug 2026 (estimated)
- Study completion1 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pink Esthetic ScoreStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- International Dental Contiuing Education
- Sponsor type
- Research network
- Responsible party
- Principal investigator, Nourhan Gamal, International Dental Contiuing Education
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07539168
- Sponsor's protocol ID
- IDCE-31042026
- Status last verified
- Apr 2026
- First submitted
- 13 Apr 2026
- Last updated
- 22 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Factors Affecting Immediate Anterior Implants Esthetics . Clinical Retrospective Study
- ClinicalTrials.gov ID
- NCT07539168
- Acronym / sponsor ID
- IDCE-31042026
- Keywords
- Immediate implant, esthetics, anterior maxilla
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- International Dental Contiuing EducationResearch network
- Study start
- 1 Jun 2026 (estimated)
- Primary completion
- 1 Aug 2026 (estimated)
- Study completion
- 1 Sep 2026 (estimated)
- First posted
- 20 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla. The primary objective is to identify predictors of implant survival and complications (e.g., infection, soft-tissue dehiscence, esthetic failure) within 12 months following placement. Secondary objectives include assessment of peri-implant marginal bone loss, prosthetic complications, and esthetic outcomes (pink esthetic score).
Detailed description
Study design:
Retrospective observational cohort study using existing patient records and radiographs from IDCE between September 2022 -March 2026. Data extraction will be performed blinded to outcome assessment.
Participants:
Subjects who received immediate implant placement in the anterior region (canine to canine) during the study period with at least 12 months follow-up. Expected sample size: approximately 500 patients/implants
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| IIP in anterior maxilla | – | –Immediate implant placement from canine to canine |
Who may qualify
- Ages
- 21 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- All patients were treated with flapless immediate implants with no grafting procedures in the esthetic zone.
Key inclusion criteria (5 listed)
- flapless immediately placed implants in esthetic zone with 3 years follow up CBCT,
- presence of immediate postoperative CBCT,
- initial intact thick gingival biotype with at least 2 mm band of keratinized tissue
- thin intact labial bone plate (< 1mm) extending 7 mm apically assessed by CBCT with good apical bone
- patients who had provided an informed consent.
Key exclusion criteria (2 listed)
- patients with medical conditions that would compromise the surgical procedures, uncontrolled diabetes mellitus, taking IV bis-phosphonates for treatment of osteoporosis
- patients with active infection related at the site of implant and patients with untreated active periodontal diseases.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Pink esthetic score
Time frame: 3 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Pink Esthetic Score
Not yet recruiting
Immediate vs Conventional Loading With Different Crown Materials on Immediately Placed Single Implants
Partial Edentulism, Dental Implant
Recruiting
Pontic Site Development With or Without Fixed Partial Denture
Mucogingival Defects, Pontic Site Development
Not yet recruiting
Peri-Implant Hard and Soft Tissue Changes After Immediate Implant Placement With Socket Shield and Immediate Restoration Versus Early Implant Placement in the Esthetic Zone
Tooth Loss in the Anterior Maxilla, Alveolar Bone Resorption
Recruiting
Immediate Implant Placement With Autogenous Maxillary Tuberosity Graft in the Esthetic Zone
Alveolar Bone Loss, Esthetic Zone Implant Rehabilitation
Recruiting
Peri-implant Soft Tissue Response to Direct Zirconia-Based Composite Customized Healing Abutment
Missing Tooth
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Pink Esthetic Score and Implant Survival Rate, run by International Dental Contiuing Education.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 22 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Nourhan Gamal, MSc (+201064249441, Nourhannegamal259@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pink esthetic score (time frame: 3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2026.